Dr. Reddy's Laboratories reports its next quarterly results on October 30, and the options market has moved to its most defensive reading of the past year in the days since the October 23 print landed with a 3.9% gain. The standout shift is in options positioning. The put/call ratio reached 4.51 on October 26, a 52-week high and more than three standard deviations above its 20-day…
Key data as of 8 Nov 2026
Dr. Reddy's Laboratories arrives at its May 29 earnings release with the same fundamental split that has defined this entire preview cycle — except the short side has just re-escalated sharply. The borrow market…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RDY — free to start on ORTEX.
Sign up for free →Open RDY on ORTEX